Athanasia Skoura
Pfizer (United States)(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, CAR-T cell therapy research, Sphingolipid Metabolism and Signaling, Monoclonal and Polyclonal Antibodies Research, Protein Degradation and Inhibitors
Most-Cited Works
- → Induction of Vascular Permeability by the Sphingosine-1-Phosphate Receptor–2 (S1P2R) and its Downstream Effectors ROCK and PTEN(2007)325 cited
- → Flow-Regulated Endothelial S1P Receptor-1 Signaling Sustains Vascular Development(2012)320 cited
- → Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization(2004)274 cited
- → MicroRNAs Are Necessary for Vascular Smooth Muscle Growth, Differentiation, and Function(2010)250 cited
- → Essential role of sphingosine 1–phosphate receptor 2 in pathological angiogenesis of the mouse retina(2007)215 cited
- → Deafness and Stria Vascularis Defects in S1P2 Receptor-null Mice(2007)193 cited
- → Sphingosine-1-Phosphate Receptor-2 Function in Myeloid Cells Regulates Vascular Inflammation and Atherosclerosis(2010)162 cited
- → Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial(2023)126 cited
- → Smooth Muscle miRNAs Are Critical for Post-Natal Regulation of Blood Pressure and Vascular Function(2011)121 cited
- → Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis(2015)120 cited